1Y Close · As of Aug 26, 2026
KBIO LABS operates in the Wholesale Trade sector.
Legal name: KBIO LABS Inc.
In fiscal year 2025, KBIO LABS (038530) reported revenue of 87.3 billion KRW, up 14.1% from 76.5 billion KRW a year earlier.
Operating profit was 1.5 billion KRW and net income was -5.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 25.9 billion KRW, with a P/B of 0.25.
These figures can be verified in the DART filing (receipt no. 20260323000803).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 87.3B | 1.5B | -5.0B |
| 2024 | 76.5B | 793M | -10.0B |
| 2023 | 27.3B | -561M | -12.7B |
| 2022 | 33.6B | -153M | -7.7B |
| 2021 | 8.7B | -4.8B | -19.5B |
Recent Filings
Trading Halt (Share Consolidation/Split Electronic Change)
Officer/Major Shareholder Ownership Report
Large Shareholding Report (General)
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-24 | Trading Halt (Share Consolidation/Split Electronic Change) |
| 2026-08-21 | Officer/Major Shareholder Ownership Report |
| 2026-08-21 | Large Shareholding Report (General) |
| 2026-08-14 | Officer/Major Shareholder Ownership Report |
| 2026-08-14 | Large Shareholding Report (General) |